Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)
Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) (A2814-GRP)
Products
Description
Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2814 |
| Target | OX Receptor |